Ming‐Ju Wu

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis

Ming‐Ju Wu, Mei‐Chin Wen, Y.-T. Chiu et al. · Kidney International · 2006 · 163 citations · Full text

Urology, Renal Disease, Renal Function +6

Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients

Ming‐Ju Wu, Ching-Yao Cheng, Cheng‐Hsu Chen et al. · Transplantation · 2011 · 115 citations

Social functioning and overall mortality: prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study.

George A. Kaplan, Thomas Wilson, Richard. D. Cohen et al. · PubMed · 1994 · 109 citations

Social Isolation, Social Determinants, Social Determinants Of Health +22